SCHEMBL7303318

SCHEMBL7303318

CCCCc1nc(C(=O)OC)c(C(=O)OC)[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KDM4C Q9H3R0 1/20 0.39
GPR84 Q9NQS5 5/20 0.38
RNASEH1 O60930 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37
PARP1 P09874 1/20 0.36
LMNA P02545 2/20 0.35
TUBB4A P04350 1/20 0.35
CYP1A2 P05177 1/20 0.35
TUBB P07437 1/20 0.35
TUBA3C P0DPH7 1/20 0.35
CYP2D6 P10635 1/20 0.35
TSHR P16473 1/20 0.35
TUBA1B P68363 1/20 0.35
TUBA4A P68366 1/20 0.35
TUBB4B P68371 1/20 0.35
TUBB3 Q13509 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29109938 0.91 LMNA (0.42) NPSR1NPC1RAB9AKDM4CGPR84
SCHEMBL784 0.90 NPSR1 (0.44) NPSR1NPC1RAB9AKDM4CRNASEH1
SCHEMBL27334926 0.84 GPR84 (0.41) NPSR1NPC1RAB9AKDM4CGPR84
SCHEMBL7309807 0.83 ALDH1A1 (0.44) NPSR1NPC1RAB9AGPR84ALDH1A1
SCHEMBL833 0.83 GPR84 (0.37) NPC1RAB9AGPR84ALDH1A1MAPK1
SCHEMBL9873189 0.83 GPR84 (0.37) NPC1RAB9AGPR84ALDH1A1MAPK1
SCHEMBL27542325 0.83 GPR84 (0.37) NPSR1NPC1RAB9AGPR84ALDH1A1
SCHEMBL27336186 0.82 GPR84 (0.36) NPC1RAB9AGPR84ALDH1A1MAPK1
SCHEMBL8653487 0.81 GPR84 (0.35) NPC1RAB9AGPR84ALDH1A1MAPK1
SCHEMBL7716174 0.80 GPR84 (0.35) NPC1RAB9AGPR84ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117098761-A Imidazo [4,5-d ] pyridazine derivatives, preparation thereof and therapeutic use thereof 赛诺菲 2023-11-21 CN disclosed
EP-0503785-B1 1-Biphenylimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-04-25 EP disclosed
EP-0545912-B1 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-04-25 EP disclosed
US-5646171-A HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 1997-07-08 US disclosed
US-5616599-A HYPOTENSIVE AGENTS FOR CARDIOVASCULAR DISORDER SANKYO COMPANY, LIMITED (JP) 1997-04-01 US disclosed
EP-0545912-A2 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1993-06-09 EP disclosed
WO-1993003033-A1 CARBONATE-SUBSTITUTED IMIDAZO[4,5-d] PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G. D. SEARLE & CO. (US) 1993-02-18 WO disclosed
EP-0503785-A1 1-Biphenylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1992-09-16 EP disclosed
WO-1991019715-A1 1H-SUBSTITUTED-IMIDAZO[4,5-d]PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-12-26 WO disclosed